SCPX
Price
$0.14
Change
-$0.00 (-0.00%)
Updated
Apr 10, 04:43 PM (EDT)
Capitalization
826.4K
VRPX
Price
$0.25
Change
+$0.02 (+8.70%)
Updated
Apr 9 closing price
Capitalization
816.57K
Ad is loading...

SCPX vs VRPX

Header iconSCPX vs VRPX Comparison
Open Charts SCPX vs VRPXBanner chart's image
SCORPIUS HOLDINGS
Price$0.14
Change-$0.00 (-0.00%)
Volume$500
Capitalization826.4K
Virpax Pharmaceuticals
Price$0.25
Change+$0.02 (+8.70%)
Volume$70.24K
Capitalization816.57K
SCPX vs VRPX Comparison Chart
Loading...
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SCPX vs. VRPX commentary
Apr 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SCPX is a Hold and VRPX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 11, 2025
Stock price -- (SCPX: $0.14 vs. VRPX: $0.25)
Brand notoriety: SCPX and VRPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SCPX: 46% vs. VRPX: 15%
Market capitalization -- SCPX: $826.4K vs. VRPX: $816.57K
SCPX [@Biotechnology] is valued at $826.4K. VRPX’s [@Biotechnology] market capitalization is $816.57K. The market cap for tickers in the [@Biotechnology] industry ranges from $281.65B to $0. The average market capitalization across the [@Biotechnology] industry is $2.01B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SCPX’s FA Score shows that 1 FA rating(s) are green whileVRPX’s FA Score has 1 green FA rating(s).

  • SCPX’s FA Score: 1 green, 4 red.
  • VRPX’s FA Score: 1 green, 4 red.
According to our system of comparison, both SCPX and VRPX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SCPX’s TA Score shows that 5 TA indicator(s) are bullish while VRPX’s TA Score has 2 bullish TA indicator(s).

  • SCPX’s TA Score: 5 bullish, 3 bearish.
  • VRPX’s TA Score: 2 bullish, 2 bearish.
According to our system of comparison, SCPX is a better buy in the short-term than VRPX.

Price Growth

SCPX (@Biotechnology) experienced а +3.41% price change this week, while VRPX (@Biotechnology) price change was -79.48% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.53%. For the same industry, the average monthly price growth was -18.05%, and the average quarterly price growth was -19.90%.

Reported Earning Dates

SCPX is expected to report earnings on Nov 11, 2024.

VRPX is expected to report earnings on May 14, 2024.

Industries' Descriptions

@Biotechnology (-7.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SCPX($826K) and VRPX($817K) have the same market capitalization . SCPX YTD gains are higher at: -56.758 vs. VRPX (-97.365). VRPX has higher annual earnings (EBITDA): -11.96M vs. SCPX (-22.84M). SCPX has more cash in the bank: 4.81M vs. VRPX (17.2K). VRPX has less debt than SCPX: VRPX (1.07M) vs SCPX (14.9M). SCPX has higher revenues than VRPX: SCPX (10M) vs VRPX (0).
SCPXVRPXSCPX / VRPX
Capitalization826K817K101%
EBITDA-22.84M-11.96M191%
Gain YTD-56.758-97.36558%
P/E RatioN/AN/A-
Revenue10M0-
Total Cash4.81M17.2K27,965%
Total Debt14.9M1.07M1,390%
FUNDAMENTALS RATINGS
SCPX: Fundamental Ratings
SCPX
OUTLOOK RATING
1..100
65
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
48

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
SCPXVRPX
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
77%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
86%
N/A
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
MACD
ODDS (%)
Bullish Trend 3 days ago
74%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
76%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VRPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JEF47.206.14
+14.95%
Jefferies Financial Group
AMPH25.231.48
+6.23%
Amphastar Pharmaceuticals
ZIMV9.560.43
+4.71%
ZimVie
ATLCP22.45-0.05
-0.22%
Atlanticus Holdings Corp
FTEL0.64-0.03
-4.38%
Fitell Corp

VRPX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VRPX has been loosely correlated with KANT. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if VRPX jumps, then KANT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VRPX
1D Price
Change %
VRPX100%
+8.78%
KANT - VRPX
48%
Loosely correlated
N/A
BOLT - VRPX
46%
Loosely correlated
+9.35%
SCPX - VRPX
37%
Loosely correlated
+19.21%
CRDF - VRPX
34%
Loosely correlated
+1.57%
RGNX - VRPX
33%
Loosely correlated
+10.92%
More